GLP-1 receptor agonist-related neuropsychiatric AEs

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-025-77395-3
中图分类号
学科分类号
摘要
引用
收藏
页码:7 / 7
相关论文
共 50 条
  • [41] EFFECT OF WEIGHT MANAGEMENT UTILIZING GLP-1 RECEPTOR AGONIST ON NAFLD
    Hefner, Anna Marie
    Pozza, Renee S.
    Barakat, Fatma
    Sweet, Patrick H., III
    Oliver, Deanna
    Hassanein, Tarek I.
    HEPATOLOGY, 2021, 74 : 1006A - 1007A
  • [42] Semaglutide GLP-1 receptor agonist Treatment of type 2 diabetes
    Chudleigh, R.
    Bain, S. C.
    DRUGS OF THE FUTURE, 2017, 42 (08) : 479 - 487
  • [43] Corrination of a GLP-1 Receptor Agonist for Glycemic Control without Emesis
    Borner, Tito
    Workinger, Jayme L.
    Tinsley, Ian C.
    Fortin, Samantha M.
    Stein, Lauren M.
    Chepurny, Oleg G.
    Holz, George G.
    Wierzba, Aleksandra J.
    Gryko, Dorota
    Nexo, Ebba
    Shaulson, Evan D.
    Bamezai, Ankur
    Rodriguez Da Silva, Valentina A.
    De Jonghe, Bart C.
    Hayes, Matthew R.
    Doyle, Robert P.
    CELL REPORTS, 2020, 31 (11):
  • [44] GLP-1 receptor agonist-induced polyarthritis: a case report
    Maria Luisa Ambrosio
    Matteo Monami
    Lavinia Sati
    Niccolò Marchionni
    Mauro Di Bari
    Edoardo Mannucci
    Acta Diabetologica, 2014, 51 : 673 - 674
  • [45] Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
    Wharton, Sean
    Blevins, Thomas
    Connery, Lisa
    Rosenstock, Julio
    Raha, Sohini
    Liu, Rong
    Ma, Xiaosu
    Mather, Kieren J.
    Haupt, Axel
    Robins, Deborah
    Pratt, Edward
    Kazda, Christof
    Konig, Manige
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (10): : 877 - 888
  • [46] Adjunct GLP-1 receptor agonist use in patients with Type 1 Diabetes
    Harkin, P.
    Crowley, R.
    McKenna, M.
    Canavan, R.
    Callanan, I
    Connolly, M.
    O'Shea, D.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2018, 187 : S205 - S205
  • [47] Pulmonary delivery of a GLP-1 receptor agonist, BMS-686117
    Qian, Feng
    Mathias, Neil
    Moench, Paul
    Chi, Cecilia
    Desikan, Sridhar
    Hussain, Munir
    Smith, Ronald L.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 366 (1-2) : 218 - 220
  • [48] A GLP-1 Receptor Agonist Inhibits Aldosterone Release in Healthy Volunteers
    Heinla, Keiu
    Vasar, Eero
    Sedman, Tuuli
    Volke, Vallo
    HORMONE AND METABOLIC RESEARCH, 2021, 53 (06) : 402 - 407
  • [49] The effect of GLP-1 receptor agonist lixisenatide on experimental diabetic retinopathy
    Oezer, Kuebra
    Kolibabka, Matthias
    Gassenhuber, Johann
    Dietrich, Nadine
    Fleming, Thomas
    Schlotterer, Andrea
    Morcos, Michael
    Wohlfart, Paulus
    Hammes, Hans-Peter
    ACTA DIABETOLOGICA, 2023, 60 (11) : 1551 - 1565
  • [50] Dulaglutide, a GLP-1 receptor agonist, for the treatment of type 2 diabetes
    Clements, Jennifer
    Moore, Katherine
    Shealy, Kayce
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2015, 10 (06) : 581 - 590